Interventions for deliberately altering blood pressure in acute stroke

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2008, Pages

  Geeganage, Chamila ^a   Bath, Philip M W ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Blood pressure *drug effects ; Calcium channel blockers *therapeutic use ; Hypertension drug therapy ; Randomized controlled trials as topic; Risk; Stroke physiopathology; *prevention control

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BENDROFLUMETHIAZIDE; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUNARIZINE; GLYCERYL TRINITRATE; ISRADIPINE; LISINOPRIL; MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID; NAFTIDROFURYL; NICARDIPINE; NIMODIPINE; NITRATE; PAPAVERINE; PENTOXIFYLLINE; PERINDOPRIL; PHENYLEPHRINE; PIRACETAM; PROSTACYCLIN; SEROTONIN ANTAGONIST; THEOPHYLLINE; THIAZIDE DIURETIC AGENT; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; UNINDEXED DRUG; VINPOCETINE;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONFIDENCE INTERVAL; DIASTOLIC BLOOD PRESSURE; HEART RATE; HUMAN; HYPERTENSION; META ANALYSIS; OUTCOME ASSESSMENT; QUALITATIVE ANALYSIS; REVIEW; STROKE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 55049122131     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD000039.pub2     Document Type: Review

References (113)

1. ACCESS 2003 {published data only} Kulschewski A, Luders S, Venneklaas U, Schoder J. Blood-pressure rhythm in acute cerebral ischemia. Analyses from the ACCESS-Study: Acute Candesartan Cilexetil Evaluation in Stroke Survivors. Deutsche Medizinische Wochenschrift 2003;128 Suppl 3:S160. [: Abst.V48]
2. Michel P, Bogousslavsky J, Kernan WN, Schrader J, Luders S, Kulschewski A, et al.ACCESS Study: blood pressure effect?. Stroke 2003;34(12):e237-8.
3. Schrader J, Luders S, Kulschewski A, Berger J, Zidek W, Treib J, et al.The ACCESS study: evaluation of acute candesarten cilexetil therapy in stroke survivors. Stroke 2003;34:1699-703.
4. Bath 2000 {published and unpublished data} * Bath, PMW, Pathansali R, Iddenden R, Bath FJ. The effect of transdermal glyceryl trinitrate, a nitric oxide donor on blood pressure and platelet function in acute stroke. Cerebrovascular Diseases 2000;11:265-72.
5. Bath PMW, Pathansali R, Bath FJ. Effect of nitric oxide on blood pressure in acute stroke. The challenge of stroke. Lancet Conference, Montreal. 1998:40-1.
6. Bath PMW, Pathansali R, Iddenden R, Bath FJ. The effect of nitric oxide, given as transdermal glyceryl trinitrate, on blood pressure in acute stroke. Cerebrovascular Diseases 1999;9 Suppl 1:101.
7. Dyker 1997 {published and unpublished data} * Dyker AG, Grosset DG, Lees K. Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischemic stroke. Stroke 1997;28:580-3.
8. Dyker AG, Grosset DG, Lees KR. Effect of perindopril on blood pressure and cerebral blood flow after acute ischaemic stroke. European Journal of Neurology 1995;2 Suppl 2:7.
9. Eames 2005 {published data only} Eames PJ, Robinson TG, Panerai RB, Potter JF. Bendrofluazide fails to reduce elevated blood pressure levels in the immediate post-stroke period. Cerebrovascular Diseases 2005;19:253-9.
10. Eveson 2007 {published and unpublished data} Eveson DJ, Robinson TG, Potter JF. Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow up. American Journal of Hypertension 2007;20:270-7.
11. Fagan 1988 120 mg {published data only} Fagan SC, Gengo FM, Bates V, Levine SR, Kinkel WR. Effect of nimodipine on blood pressure in acute ischemic stroke in humans. Stroke 1988;19:401-2.
12. Fagan 1988 240 mg {published data only} Fagan SC, Gengo FM, Bates V, Levine SR, Kinkel WR. Effect of nimodipine on blood pressure in acute ischemic stroke in humans. Stroke 1988;19:401-2.
13. Hillis 2003 {published and unpublished data} Hillis AE, Ulatowski JA, Barker PB, Torbey M, Ziai W, Beauchamp NJ, et al.A pilot randomised trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke. Cerebrovascular Diseases 2003;16:236-48.
14. INTERACT pilot 2008 {published data only} Anderson C. INTERACT: Intensive blood pressure reduction in acute cerebral haemorrhage trial. http://www.thegeorgeinstitute.org/research/neurological-diseases 2005.
15. Anderson CS, Butcher K, Huang Y, Morgenstern L. INTERACT (Intensive blood pressure reduction in acute cerebral haemorrhage trial): rationale, design, and early results. Journal of the Neurological Sciences 2005;238 Suppl 1:S381.
16. Anderson CS, Huang Y, Wang J, Morgenstern L, Butcher K, Neal B, et al.INTERACT (Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial) rationale and design. Proceedings of the International Stroke Conference. 2006.
17. * Anderson CS, Huang Y, Wang JG, Arima H, Neal B, Peng B, et al.Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurology 2008;7(5):391-9.
18. Lisk 1993 {published and unpublished data} Lisk DR, Grotta JC, Lamki LM, Tran HD, Taylor JW, Molony DA, et al.Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography. Archives of Neurology 1993;50:855- 62.
19. Rashid 2003 10 mg {published and unpublished data} Rashid P, Weaver C, Leonardi-Bee J, Bath F, Fletcher S, Bath P. The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac haemodynamics, and plasma nitric oxide levels in acute stroke. Journal of Stroke and Cerebrovascular Diseases 2003;12(3):143-51.
20. Rashid 2003 5 mg {published and unpublished data} Rashid P, Weaver C, Leonardi-Bee J, Bath F, Fletcher S, Bath P. The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac haemodynamics, and plasma nitric oxide levels in acute stroke. Journal of Stroke and Cerebrovascular Diseases 2003;12(3):143-51.
21. Rashid 2003 5/10 mg {published and unpublished data} Rashid P, Weaver C, Leonardi-Bee J, Bath F, Fletcher S, Bath P. The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac haemodynamics, and plasma nitric oxide levels in acute stroke. Journal of Stroke and Cerebrovascular Diseases 2003;12(3):143-51.
22. Uzuner 1995 {published and unpublished data} Uzuner N, Gucuyener D, Ozdemir G. The interaction between nimodipine and systemic blood pressure and pulse rate. Unpublished manuscript.
23. Uzuner N, Ozdemir G, Gucuyener D. The interaction between nimodipine and systemic blood pressure and pulse rate. Pan-European consensus meeting on stroke management. 8-10 November 1995, Helsingborg, Sweden. 1995.
24. Willmot 2006 {published and unpublished data} Willmot M, Ghadami A, Clarke W, Weaver C, Wardlaw J, Bath P. Effect of glyceryl tri-nitrate, a nitric oxide donor, on blood pressure and cerebral blood flow in acute/subacute stroke. Journal of the Neurological Sciences 2005;238 Suppl 1:Abst OPL104.
25. Willmot M, Ghadami A, Whysall B, Clarke W, Wardlaw J, Bath PMW. Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension 2006;47:1209-15.
26. Willmot M, Ghadami A, Whysall B, Weaver C, Bath P. Glyceryl trinitrate, a nitric oxide donor, lowers blood pressure but not cerebral blood flow in patients with acute/subacute stroke. Cerebrovascular Diseases 2005;19 Suppl 2:31.
27. Alem 2005 {published data only} Alem M, Milia P, Muir S, Lees K, Walters M. Comparison of the effects of diuretics on blood pressure and arterial stiffness in stroke patients. Cerebrovascular Diseases 2005;19 Suppl 2:142.
28. Carlsson 1993 {unpublished data only} Carlsson A. Management of high blood pressure in stroke patients. Thesis 1993.
29. Hartmann 2005 {published data only} Hartmann A, Pavlidis C, Dettmers C, Rommel T. The effect of antihypertensive drugs on intracranial pressure and cerebral blood flow in patients with acute stroke. Cerebrovascular Diseases 2005;19 Suppl 2:2.
30. Koenig 2006 {published data only} Koenig MA, Geocadin RG, de Grouchy M, Glasgow J, Vimal S, Restrepo L, et al.Safety of induced hypertension therapy in patients with acute ischemic stroke. Neurocritical Care 2006;4:3-7.
31. Marzan 2004 {published data only} Marzan AS, Hungerbühler HJ, Studer A, Baumgartner RW, Georgiadis D. Feasibility and safety of norepinephrine-induced arterial hypertension in acute ischemic stroke. Neurology 2004;62:1193-5.
32. Meier 1991 {published data only} Meier F, Wessel G, Thiele R, Gottschild D, Brandstatt H. Induced hypertension as an approach to treating acute cerebrovascular ischaemia: possibilities and limitations. Experimental Pathology 1991;42:257-63.
33. Naidech 2003 {published data only} Naidech A, Khasani S, Lafaye K, Martin J, Weisberg L. Chart review and pilot study of blood pressure control in acute ischemic stroke. Journal of the Louisiana State Medical Society 2003;155:99-102.
34. Nakamura 2007 {published data only} Nakamura T, Uchiyama S, Tsutsumi Y, Shimizu Y, Iwata M. Renin-angiotensin system blockade safely reduces blood pressure without affecting cerebral blood flow in patients with acute ischemic stroke. Stroke 2007;38(2):517.
35. Nazir 2004 {published data only} Nazir FS, Overell JR, Bolster A, Hilditch TE, Reid JL, Lees KR. The effect of losartan on global and focal cerebral perfusion and on renal function in hypertensives in mild early ischaemic stroke. Journal of Hypertension 2004;22:989-95.
36. Nazir 2005 {published data only} Nazir FS, Overell JR, Bolster A, Hilditch TE, Lees KR. Effect of perindopril on cerebral and renal perfusion on normotensives in mild early ischaemic stroke: a randomised controlled trial. Cerebrovascular Diseases 2005;19:77-83.
37. Popa 1995 {published data only} Popa G, Voiculescu V, Popa C, Stanescu A, Nistorescu A, Jipescu I. Stroke and hypertension, antihypertensive therapy withdrawal. Romanian Journal of Neurology and Psychiatry 1995;33:29-36.
38. Powers 1999 {published data only} Powers WJ, Adams RE, D Yundt K, Manno EM, Diebert E, Zazulia A, et al.Acute pharmacological hypotension after intracerebral hemorrhage does not change cerebral blood flow. Stroke 1999;30:242.
39. ACCOST 2006 {published data only} O'Brien RE, O'Connell JE, Hildreth AJ, Palmer L, Johnston D, Gray CS. Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST). Proceedings of the International Stroke Conference. 16 February 2006. [: Abst. CTP52]
40. ATACH 2006 {published data only} Qureshi AI. ATACH antihypertensive treatment in acute cerebral hemorrhage. Stroke Trials Directory, Internet Stroke Center 2006.
41. CHHIPS 2005 {published data only} Mistri A, Potter J, Robinson T. Controlling hypertension and hypotension immediately post stroke (CHHIPS) - ongoing clinical trial. Proceedings of the BASP: British Association of Stroke Physicians Annual Scientific Meeting. 19 January 2005.
42. Mistri A, Potter JF, Robinson TG. Controlling hypertension and hypotension immediately post stroke (CHHIPS) - ongoing trial. Journal of Neurology Neurosurgery and Psychiatry 2005;76(1):154-5.
43. Mistri AK, Potter JF, Robinson TG. Controlling hypertension and hypotension immediately post stroke (CHHIPS). Proceedings of the International Stroke Conference. 2 February 2005.
44. The CHHIPS trial group. CHHIPS (Controlling Hypertension and Hypotension Immediatly Post-Stroke) pilot trial: rationale and design. Journal of Hypertension 2005;23:649-55.
45. COSSACS 2005 {published data only} COSSACS Trial Group. COSSACS (Continue or Stop post-Stroke Antihypertensive Collaborative Study): rationale and design. Jounal of Hypertension 2005;23(2):455-58.
46. ENOS 2006 {published data only} Major Ongoing Stroke Trials. Stroke 2001; Vol. 32:2448-57.
47. Bath P, Gray L, Sprigg N. The efficacy of nitric oxide in stroke (ENOS) trial: baseline characteristics of the first 279 patients. Proceedings of the BASP: British Association of Stroke Physicians Annual Scientific Meeting. 19 January 2005.
48. Bath PM. Efficacy of nitric oxide in stroke (ENOS) trial - a prospective randomised controlled trial in acute stroke. Proceedings of the International Stroke Conference. 2 February 2005.
49. Gray L, Sprigg N, Willmot M, Ferentzi U, Weaver C, Bath PMW, for the ENOS Investigators. The Efficacy of Nitric Oxide in Stroke (ENOS) trial: baseline characteristics of the first 301 patients. Cerebrovascular Diseases 2005;19 Suppl 2:75.
50. Gray LJ, Sare GM, Utton S, Bath PMW. Efficacy of Nitric Oxide in Stroke (ENOS) Trial - a prospective randomised controlled trial in acute stroke. Proceedings of the 16th European Stroke Conference. Glasgow, 2007:8.
51. The ENOS Trial Investigators. Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rational and design of the Efficacy of Nitric oxide in Stroke (ENOS) trial (ISRCTN99414122). International Journal of Stroke 2006;1:245-9.
52. Geeganage 2007 {published data only} Geeganage C, Bath PMW. An assessment of the effects of altering blood pressure on cerebral and systemic haemodynamics in patients with acute ischaemic stroke. Unpublished 2007.
53. ICH ADAPT-E 2007 {published data only} Butcher K. ADAPT-E Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial - Extended. Stroke Trials Directory, Internet Stroke Center: www.strokecenter.org/trials/ 2007.
54. INTERACT2 2008 {published data only} Anderson C. INTERACT2 the second intensive blood pressure reduction in acute cerebral haemorrhage trial. Stroke Trials Directory, Internet Stroke Center 2008.
55. SCAST 2005 {published data only} Aakvik R. SCAST: Scandinavian Candesartan Acute Stroke Trial. Stroke Trials Directory, Internet Stroke Center 2005.
56. Berge E, Aakvik R, Terent A, Boysen G. Scandinavian Candesartan Acute Stroke Trial (SCAST). Cerebrovascular Diseases 2006;21 Suppl 4:124-5.
57. Iuell RS, Aarhus D, Terent A, Boysen G, Thijs V, Berge E. SCAST - Scandinavian Candesartan Acute Stroke Trial. Proceedings of the 16th European Stroke Conference. 29 May - 1 June 2007.
58. TAST 2006 {published data only} Sare G, Aur D, Bath PMW. Effect of an angiotensin receptor antagonist on cerebral blood flow, cerebral perfusion pressure, and systemic and peripheral haemodynamics in patients with acute stroke. Unpublished 2006.
59. Adams 1965 Adams GF. Prospects for patients with strokes, with special reference to the hypertensive hemiplegic. British Medical Journal 1965;ii:253-9.
60. AHA-HS 2007 Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, et al.Guidelines for the management of spontaneous intracerebral hemorrhage in adults 2007 update. Stroke 2007;38:2001-23.
61. AHA-IS 2007 Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al.Guidelines for the early management of adults with ischemic stroke. Stroke 2007;38:1655-711.
62. BASC 2000 Blood Pressure in Acute Stroke Collaboration. Vasoactive drugs for acute stroke. Cochrane Database of Systematic Reviews 2000, Issue 4. [Art. No.: CD002839. DOI: 10.1002/14651858.CD002839]
63. Bath 1997 Bath FJ, Bath PMW. What is the correct management of blood pressure in acute stroke? The Blood pressure in Acute Stroke Collaboration. Cerebrovascular Diseases 1997;7:205-13.
64. Bath 2002 Bath PMW, Willmot M, Leonardi-Bee J, Bath-Hextall FJ. Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke. Cochrane Database of Systematic Reviews 2002, Issue 4. [Art. No.: CD000398. DOI: 10.1002/14651858.CD000398]
65. Bath 2003 Bath P, Chalmers J, Powers W, Beilin L, Davis S, Lenfant C, et al.International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. Journal of Hypertension 2003;21(4):665-72.
66. Bath 2004a Bath PMW, Bath-Hextall FJ. Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2004, Issue 3. [Art. No.: CD000162. DOI: 10.1002/14651858.CD000162.pub2]
67. Bath 2004b Bath PMW. Prostacyclin and analogues for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2004, Issue 3. [Art. No.: CD000177. DOI: 10.1002/14651858.CD000177.pub2]
68. Bourestom 1967 Bourestom NC. Predictors of long term recovery in cerebrovascular disease. Archives of Physical Medicine and Rehabilitation 1967;48:415-9.
69. Bridgers 1991 Bridgers SL, Koch G, Munera C, Karwon M, Kurtz NM. Intravenous nimodipine in acute stroke: interim analysis of randomised trials. Stroke 1991;22:153.
70. Britton 1980 Britton M, de Faire U, Helmers C. Hazards of therapy for excessive hypertension in acute stroke. Acata Medica Scandinavica 1980;207:253-7.
71. Britton 1986 Britton M, Carlsson A, de Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke 1986;17:861-4.
72. Burke 1986 Burke AM, Younkin D, Gordon J, Goldberg H, Graham T, Kushner M, et al.Changes in cerebral blood flow and recovery from acute stroke. Stroke 1986;17:173-8.
73. Butterworth 1998 Butterworth RJ, Chickie A, Jackson SHD, Buxton-Thomas M, Bath PMW. Sodium nitroprusside a spontaneous nitric oxide donor in acute ischaemic stroke. Cerebrovascular Diseases 1998;8:158- 65.
74. Carlberg 1993 Carlberg B, Asplund K, Hagg E. The prognostic value of admission blood pressure in patients with acute stroke. Stroke 1993;24:1372-5.
75. Castillo 2004 Castillo J, Leira R, García MM, Serena J, Blanco M, Dávalos A. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke 2004;35(2):520-6.
76. Chamorro 1998 Chamorro A, Vila N, Ascaso C, Elices E, Schonewille W, Blanc R. Blood pressure and functional recovery in acute ischemic stroke. Stroke 1998;29:1850-3.
77. Dandapani 1995 Dandapani B, Suzuki S, Kelley RE, Reyes-Iglesias Y, Duncan RC. Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 1995;26:21-4.
78. Droller 1965 Droller H. The outlook in hemiplegia. Geriatrics 1965;20:630-6.
79. EUSI 2004 Toni D, Chamorro A, Kaste M, Lees K, Wahlgren NG, Hacke W. Acute treatment of ischaemic stroke. Cerebrovascular Diseases 2004;17 Suppl 2:30-46.
80. Fischberg 2000 Fischberg GM, Lozano E, Rajamani K, Ameriso S, Fisher MJ. Stroke precipitated by moderate blood pressure reduction. Journal of Emergency Medicine 2000;19:339-46.
81. Fujii 1994 Fujii Y, Tanaka R, Takeuchi S, Koike T, Minakawa T, Sasaki O. Hematoma enlargement in spontaneous intracerebral hemorrhage. Journal of Neurosurgery 1994;80:51-7.
82. Fujii 1998 Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Tanaka R. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 1998;29:1160-6.
83. Furberg 1995 Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose-related increase inmortality in patients with coronary heart disease. Circulation 1995;92:1326-31.
84. Graham 1975 Graham DI. Ischaemic brain damage after cerebral perfusion failure after treatment of severe hypertension. British Medical Journal 1975;4:739.
85. Hakim 1989 Hakim AM, Evans AC, Berger L, Kuwabara H, Worsley K, Marchal G, et al.The effect of nimodipine on the evolution of human cerebral infarction studied by PET. Journal of Crebral Blood Flow and Metabolism 1989;9(4):523-34.
86. Harper 1994 Harper G, Castleden CM, Potter JF. Factors effecting changes in blood pressure after acute stroke. Stroke 1994;25:1726- 9.
87. HOPE 2000 The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. New England Journal of Medicine 2000;342:145-53.
88. Horn 2001 Horn J, Limburg M. Calcium antagonists for ischemic stroke: a systematic review. Stroke 2001;32:570-6.
89. Kazui 1997 Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke 1997;28:2370-5.
90. Kloner 1995 Kloner RA. Nifedipine in ischemic heart disease. Circulation 1995;92:1074-8.
91. Leonardi-Bee 2002 Leonardi-Bee J, Bath PMW, Phillips SJ, Sandercock PAG. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002;33:1315-20.
92. Marquarsden 1969 Marquarsden J. The natural history of acute cerebrovascular disease: a retrospective study of 769 patients. Acta Neurologica Scandinavica 1969;45 Suppl 38:118-24.
93. Marshall 1959 Marshall J, Shaw DA. The natural history of cerebrovascular disease. British Medical Journal 1959;i:1614-7.
94. Myers 1982 Myers M, Norris J, Hachinski V, Weingert M, Sole M. Cardiac sequelae of acute stroke. Stroke 1982;13:838-42.
95. O'Connell 1994 O'Connell JE, Gray CS. Treating hypertension after stroke. BMJ 1994;308:1523-4.
96. Oppenheimer 1992 Oppenheimer S, Hachinski V. Complications of acute stroke. Lancet 1992;339:721-4.
97. Paulson 1990 Paulson OB, Strandgaard S, Edvinsson L. Cerebral autoregulation. Cerebrovascular and Brain Metabolism Reviews 1990;2:161-92.
98. PROGRESS 2001 PROGRESS Collaborative group. Randomised trial of a perindopril-based blood pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41.
99. Rashid 2003 Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003;34:2741-8.
100. Rodgers 1996 Rodgers A, MacMahon S, Gamble G, Slattery J, Sandercock P, Warlow C, for the United Kingdom Transient Ischaemic Attack Collaborative Group. Blood pressure and risk of stroke in patients with cerebrovascular disease. BMJ 1996;313:147.
101. Rordorf 1997 Rordorf G, Kramer RG, Esird JT, Schwamm LH, Buonanno S, Koroshetz WJ, et al.Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. Stroke 1997;28:2133-8.
102. Sandercock 1992 Sandercock P, Willems H. Medical treatment of acute ischaemic stroke. Lancet 1992;339:537-9.
103. Spence 1985 Spence JD, del Maestro RF. Hypertension in acute ischaemic strokes. Treat. Archives of Neurology 1985;42:1000-2.
104. Sprigg 2005 Sprigg N, Bath PMW. Management of blood pressure in acute stroke. Practical Neurology 2005;5:218-23.
105. Sprigg 2006 Sprigg N, Gray LJ, Bath PMW, Boysen G, De Deyn PP, Friss P, et al.Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial. Journal of Hypertension 2006;24(7):1413-8.
106. Strandgaard 1973 Strandgaard S, Olesen J, Skinhoj E, Lassen NA. Autoregulation of brain circulation in severe arterial hypertension. British Medical Journal 1973;3:507-10.
107. Stroke Center Stroke Trials Registry. http://www.strokecenter.org/ trials/.
108. Vemmos 2004 Vemmos KN, Tsivgoulis G, Spengos K, Zakopoulos N, Synetos A, Manios E, et al.U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. Journal of Internal Medicine 2004;255:257-65.
109. Wahlgren 1994 Wahlgren NG, MacMahon DG, De Keyser J, Indredavik B, Ryman T, for the INWEST Study Group. Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke. Cerebrovascular Diseases 1994;4:204-10.
110. Wallace 1981 Wallace JD, Levy LL. Blood pressure after stroke. Journal of the American Medical Association 1981;246:2177-80.
111. Willmot 2004 Willmot M, Leonardi-Bee J, Bath PMW. High blood pressure in acute stroke and subsequent outcome: A systematic review. Hypertension 2004;43:18-24.
112. Yatsu 1985 Yatsu FM, Zivin J. Hypertension in acute ischaemic strokes. Not to treat. Archives of Neurology 1985;42:999-1000.
113. BASC 2001 Blood Pressure in Acute Stroke Collaboration. Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database of Systematic Reviews 2001, Issue 3. [〈!DOCTYPEHTML PUBLIC "-//W3C//DTDHTML 4.0 Transitional// EN"〉〈HTML xmlns:old="http://cochrane.org/ old"〉〈HEAD〉〈TITLE〉Interventions for deliberately altering blood pressure in acute stroke〈/TITLE〉〈LINK href="http://archie.cochrane.org/css/revmanArt. No.: CD000039. DOI: 10.1002/14651858.CD000039]